Imcyse Raises €21.3M to Advance Treatments for MS, Other Diseases

Imcyse Raises €21.3M to Advance Treatments for MS, Other Diseases

288436

Imcyse Raises €21.3M to Advance Treatments for MS, Other Diseases

Imcyse has raised €21.3 million ($25.8 million) in funding to advance its innovative immunotherapy platform for the treatment of multiple sclerosis (MS) and other severe autoimmune diseases. The funding was a result of a series B financing round featuring existing investors such as Biogenosis, Société Fédérale de Participations et d’Investissement, and the Catholic University of Leuven, as well as the newest investor Pfizer, which took an equity stake as part of a previously announced licensing…

You must be logged in to read/download the full post.